76,390 results match your criteria Percutaneous Coronary Intervention

Stent Dislodgment and Retrieval During Percutaneous Coronary Intervention.

J Invasive Cardiol 2022 Jul;34(7):E574-E575

Unità Operativa Complessa di Cardiologia Clinica e Interventistica, Ospedale SS Annunziata, Sassari, Italy.

During PCI, stent entrapment and dislodgment in the coronary arteries is a rare but potentially fatal complication that can lead to emergent cardiac surgery. Percutaneous stent retrieval is an alternative way to solve this challenging complication while avoiding cardiac surgery. Read More

View Article and Full-Text PDF

Side Branch Late Thrombosis After Left Main Coronary Artery Crossover Stenting.

Cardiol Ther 2022 Jun 30. Epub 2022 Jun 30.

Heart Center, Segeberger Kliniken GmbH, Academic Teaching Hospital of the Universities of Kiel, Lübeck, Hamburg, Am Kurpak 1, 23795, Bad Segeberg, Germany.

Background: With the established use of crossover stenting technique in bifurcation coronary artery lesions, added clinical benefit of final kissing of the side branch remains debatable. We report a case of a stenosis and thrombus formation of an ostial side branch after crossover stenting. A 38-year-old man was admitted with acute coronary syndrome complicated by acute pulmonary oedema. Read More

View Article and Full-Text PDF

Impact of Short-Term Heart Rate Variability in Patients with STEMI Treated by Delayed versus Immediate Stent in Primary Percutaneous Coronary Intervention: A Prospective Cohort Study.

Comput Math Methods Med 2022 20;2022:2533664. Epub 2022 Jun 20.

School of Medicine, South China University of Technology, Guangzhou Higher Education Mega Centre, Panyu District, Guangzhou 510006, China.

Objective: Patients with ST-segment elevated myocardial infarction (STEMI) have been treated with the delayed stent strategy to reduce the occurrence of postoperative no-reflow and improve the recovery of postoperative cardiac function. However, the effects of electrocardiac activity and autonomic nerve function after primary percutaneous coronary intervention (pPCI) have been rarely reported. The purpose of this study was to investigate the effects of short-term heart rate variability (HRV) in patients with STEMI treated by immediate stent (IS) and delayed stent (DS) strategy. Read More

View Article and Full-Text PDF

Outcomes in ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention or pharmacoinvasive strategy in a Latin American country.

BMC Cardiovasc Disord 2022 Jun 29;22(1):296. Epub 2022 Jun 29.

Centro de Excelencia en Investigaciones Económicas y Sociales en Salud, Vicerrectorado de Investigación, Universidad San Ignacio de Loyola, Lima, Peru.

Objective: The primary percutaneous coronary intervention (PPCI) is the preferred reperfusion strategy for ST-segment elevation myocardial infarction (STEMI). The pharmacoinvasive strategy (PIs) is a reasonable alternative when prompt PPCI is not possible, especially in resource-limited regions. We aimed to compare PPCI versus PIs outcomes in Peru. Read More

View Article and Full-Text PDF

Revascularisation for the proximal left anterior descending artery: special case or part of the package?

Heart 2022 Jun 29. Epub 2022 Jun 29.

Infection, Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, UK.

View Article and Full-Text PDF

Prognostic and diagnostic accuracy of intracoronary electrocardiogram recorded during percutaneous coronary intervention: a meta-analysis.

BMJ Open 2022 Jun 29;12(6):e055871. Epub 2022 Jun 29.

Department of Cardiology, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, China

Objective: Intracoronary ECG (IC-ECG) recording has been shown to be sensitive and reliable for detecting myocardial viability and local myocardial ischaemia in some studies. But IC-ECG is neither widely used during percutaneous coronary intervention (PCI) nor recommended in guidelines. This up-to-date meta-analysis of published studies was conducted to evaluate the prognostic and diagnostic accuracy of IC-ECG recorded during PCI. Read More

View Article and Full-Text PDF

Predictors of left ventricular ejection function decline in young patients with ST-segment elevation myocardial infarction.

Rev Assoc Med Bras (1992) 2022 24;68(6):802-807. Epub 2022 Jun 24.

Osmaniye State Hospital, Department of Cardiology - Osmaniye, Turkey.

Objective: A decrease in the left ventricular ejection fraction (≤40%) in the setting of ST-segment elevation myocardial infarction is a significant predictor of mortality in the young ST-segment elevation myocardial infarction population. In this study, we aimed to investigate the predictors of left ventricular ejection fraction reduction and evaluate the long-term mortality rates in young ST-segment elevation myocardial infarction patients with or without decreased left ventricular ejection fraction.

Methods: We enrolled retrospectively 411 consecutive ST-segment elevation myocardial infarction patients aged 45 years or below who underwent primary percutaneous coronary intervention. Read More

View Article and Full-Text PDF

Systemic Immune-Inflammatory Index as a Determinant of Atherosclerotic Burden and High-Risk Patients with Acute Coronary Syndromes.

Arq Bras Cardiol 2022 Jun 27. Epub 2022 Jun 27.

Namik Kemal University,Faculty of Medicine, Department of Cardiovascular Surgery, Tekirdag - Turquia.

Background: Systemic immune-inflammatory index (SII), which is derived from neutrophil, platelet and lymphocyte counts, represents the homeostatic balance among inflammatory, immune and thrombotic status. The systemic immune-inflammatory index is superior to indices such as neutrophil-lymphocyte ratio in predicting prognosis in various malignancies, while it is shown to predict future cardiac events better than traditional risk factors after coronary intervention.

Objectives: Herein, we aimed to evaluate the relationship of the systemic immune-inflammatory index with atherosclerotic burden and in-hospital complications in acute coronary syndrome patients. Read More

View Article and Full-Text PDF

Alternative Application Technique for the MANTA Vascular Closure Device for Percutaneous Large-Bore Arterial Access Closure: The Fluoroscopic DOT Technique.

J Endovasc Ther 2022 Jun 29:15266028221105187. Epub 2022 Jun 29.

Division of Cardiovascular Diseases, Lankenau Medical Center, Lankenau Institute of Medical Research, Wynnewood, PA, USA.

Background: Vascular complications are a cause of increased morbidity and mortality when performing percutaneous procedures requiring large-bore arterial access. MANTA vascular closure device (VCD) is currently the only large-bore VCD using an intraluminal foot plate and an extraluminal collagen plug. The traditional depth locator approach might be compromised in; emergent cases without the required measurements, cases of hematoma formation, or other patient, procedure, or operator-specific variables. Read More

View Article and Full-Text PDF

Neuropeptide-Y Levels in ST-Segment-Elevation Myocardial Infarction: Relationship With Coronary Microvascular Function, Heart Failure, and Mortality.

J Am Heart Assoc 2022 Jun 29:e024850. Epub 2022 Jun 29.

Department of Physiology, Anatomy and Genetics, Burdon Sanderson Cardiac Science Centre University of Oxford United Kingdom.

Background The sympathetic cotransmitter, neuropeptide Y (NPY), is released into the coronary sinus during ST-segment-elevation myocardial infarction and can constrict the coronary microvasculature. We sought to establish whether peripheral venous (PV) NPY levels, which are easy to obtain and measure, are associated with microvascular obstruction, myocardial recovery, and prognosis. Methods and Results NPY levels were measured immediately after primary percutaneous coronary intervention and compared with angiographic and cardiovascular magnetic resonance indexes of microvascular function. Read More

View Article and Full-Text PDF

Multifaceted Intervention to Improve P2Y12 Inhibitor Adherence After Percutaneous Coronary Intervention: A Stepped Wedge Trial.

J Am Heart Assoc 2022 Jun 29:e024342. Epub 2022 Jun 29.

Baylor College of Medicine Houston TX.

Background P2Y12 inhibitor medications are critical following percutaneous coronary intervention (PCI); however, adherence remains suboptimal. Our objective was to assess the effectiveness of a multifaceted intervention to improve P2Y12 inhibitor adherence following PCI. Methods and Results This was a modified stepped wedge trial of 52 eligible hospitals, of which 15 were randomly selected and agreed to participate (29 hospitals declined, and 8 eligible hospitals were not contacted). Read More

View Article and Full-Text PDF

Variation in practice for out-of-hospital cardiac arrest treated with percutaneous coronary intervention in England and Wales.

Catheter Cardiovasc Interv 2022 Jun 29. Epub 2022 Jun 29.

Faculty of Medicine, University of Southampton, Southampton, UK.

Objectives: We assessed the association between total center volume, operator volume, and out-of-hospital cardiac arrest (OHCA) percutaneous coronary intervention (PCI) volume.

Background: Variations between OHCA PCI volume, hospital total PCI, and primary PCI volume are not well studied and are unlikely to be clinically justifiable.

Methods: Patients undergoing PCI for the acute coronary syndrome (ACS) between January 1, 2014, and March 31, 2019, in England and Wales were grouped as OHCA PCI and non-OHCA PCI. Read More

View Article and Full-Text PDF

Utility of prehospital electrocardiogram interpretation in ST-segment elevation myocardial infarction utilizing computer interpretation and transmission for interventional cardiologist consultation.

Catheter Cardiovasc Interv 2022 Jun 29. Epub 2022 Jun 29.

Department of Cardiology, Liverpool Hospital, Sydney, New South Wales, Australia.

Objectives: We examined the appropriateness of prehospital cardiac catheter laboratory activation (CCL-A) in ST-segment elevation myocardial infarction (STEMI) utilizing the University of Glasgow algorithm (UGA) and remote interventional cardiologist consultation.

Background: The incremental benefit of prehospital electrocardiogram (PH-ECG) transmission on the diagnostic accuracy and appropriateness of CCL-A has been examined in a small number of studies with conflicting results.

Methods: We identified consecutive PH-ECG transmissions between June 2, 2010 and October 6, 2016. Read More

View Article and Full-Text PDF

A graceless man still needs grace.

Laura A Katers

JAAPA 2022 07;35(7):66

Laura A. Katers practices inpatient pain management and addiction medicine at the University of Washington Medical Center in Seattle, Wash., and teaches in the MEDEX Northwest PA program. You can follow her interest in art and medicine on Instagram at The author has disclosed no potential conflicts of interest, financial or otherwise.

View Article and Full-Text PDF

A comparison of the effect of fentanyl versus morphine on the antiplatelet effects of ticagrelor in patients with ST-segment elevation myocardial infarction: Full results of the PERSEUS randomized trial.

Cardiol J 2022 Jun 28. Epub 2022 Jun 28.

Cardiology Division of the University Hospital of Geneva, Switzerland.

Background: Morphine reduces absorption and delays action onset of potent oral P2Y₁₂ receptor inhibitors in patients with ST-segment elevation myocardial infarction (STEMI). We sought to determine the differential effects of fentanyl compared to morphine on the pharmacodynamics and pharmacokinetics of ticagrelor in STEMI patients undergoing primary percutaneous coronary intervention (PCI).

Methods: PERSEUS (NCT02531165) was a prospective, single-center, open-label, randomized controlled study. Read More

View Article and Full-Text PDF

Catheter-induced coronary artery and aortic dissections. A study of the mechanisms, risk factors, and propagation causes.

Cardiol J 2022 Jun 28. Epub 2022 Jun 28.

Department of Cardiology and Interventional Angiology, Kashubian Center for Heart and Vascular Diseases in Wejherowo, Pomeranian Hospitals, Wejherowo, Poland.

Background: Only the incidence, management, and prognosis of catheter-induced coronary artery and aortic dissections have been systematically studied until now. We sought to evaluate their mechanisms, risk factors, and propagation causes.

Methods: Electronic databases containing 76,104 procedures and complication registries from 2000-2020 were searched and relevant cineangiographic studies adjudicated. Read More

View Article and Full-Text PDF

Assessment of the Efficacy and Safety of Early Intracoronary Nicorandil Administration in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.

Cureus 2022 May 26;14(5):e25349. Epub 2022 May 26.

Cardiology, Shyam Shah Medical College, Rewa, IND.

Background No-reflow phenomenon (NRP) remains a challenge in ST-elevation myocardial infarction (STEMI) patients. We determined the efficacy and safety of early intracoronary administration of nicorandil as an adjunct to primary percutaneous coronary intervention (pPCI) in STEMI patients to reduce the risk of NRP. Materials and methods In this single-center case-control prospective study, 100 STEMI patients who underwent pPCI had thrombectomy performed using a suction catheter, and tirofiban (10 mg/kg) was injected distal to the vascular lesion. Read More

View Article and Full-Text PDF

The challenges of percutaneous coronary intervention and dual antiplatelet therapy in cancer patients.

Cardiovasc Revasc Med 2022 Jun 18. Epub 2022 Jun 18.

Pauley Heart Center, Virginia Commonwealth University Medical Center, Richmond, VA, United States of America; McGuire Veterans Affairs Medical Center, Richmond, VA, United States of America. Electronic address:

View Article and Full-Text PDF

Safety and Efficacy of Ultra Short-Duration Dual Antiplatelet Therapy After Percutaneous Coronary Interventions: A Meta analysis of Randomized Controlled Trials.

Curr Probl Cardiol 2022 Jun 24:101295. Epub 2022 Jun 24.

Department of Clinical Medical Education, University of Tennessee at Nashville, Nashville, TN, USA; Ascension Healthcare Cardiovascular Service Line. Electronic address:

Introduction: Dual antiplatelet therapy (DAPT) is required after percutaneous coronary intervention (PCI) to reduce stent thrombosis, but DAPT increases bleeding risks. The optimal duration of DAPT that provides the maximum protective ischemic effect along with the minimum bleeding risk is unclear. This is the first meta-analysis comparing outcomes for 1-month versus longer DAPT strategies following PCI. Read More

View Article and Full-Text PDF

Release of MMP-2 in the circulation of patients with acute coronary syndromes undergoing percutaneous coronary intervention: Role of platelets.

Thromb Res 2022 Jun 22;216:84-89. Epub 2022 Jun 22.

Department of Medicine and Surgery, Division of Internal and Cardiovascular Medicine, University of Perugia, Perugia, Italy. Electronic address:

Introduction: Matrix metalloproteinases (MMPs) of atherosclerotic tissue contribute to plaque rupture triggering acute coronary syndromes (ACS). Several MMPs, including MMP-2, are also contained in platelets and released upon activation. An increase in circulating levels of MMP-2 has been reported in patients undergoing percutaneous coronary interventions (PCI), but its time-course and origin remain unclear. Read More

View Article and Full-Text PDF

Prognostic impact of pre-interventional culprit artery thrombolysis in myocardial infarction (TIMI) flow in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention.

Egypt Heart J 2022 Jun 27;74(1):52. Epub 2022 Jun 27.

Cardiology Department, Ain Shams University, 38 Ramsis Street, El Abbaseya, Cairo, Egypt.

Background: Primary percutaneous coronary intervention (PCI) is considered the most preferred strategy in ST-segment elevation myocardial infarction (STEMI). However, the prognostic role of spontaneous re-canalization in STEMI patients is still not clear. The purpose of this study is to evaluate the impact of pre-procedural TIMI flow grade in the culprit coronary artery on the short and long term prognosis in Egyptian patients presented with STEMI and treated with primary PCI. Read More

View Article and Full-Text PDF

Dose-dependent effect of impaired renal function on all-cause mortality in patients following percutaneous coronary intervention.

Clin Cardiol 2022 Jun 27. Epub 2022 Jun 27.

Department of Internal Medicine, Cardiology Unit, Pharmongkutklao Hospital, Bangkok, Thailand.

Objective: To determine the risk prediction of various degrees of impaired renal function on all-cause mortality in patients following percutaneous coronary intervention (PCI).

Background: Patients with chronic kidney disease (CKD) are at high risk of all-cause mortality after PCI. However, there are less data of various degrees of impaired renal function to predict those risks. Read More

View Article and Full-Text PDF

Coronary sinus reducer for the treatment of chronic refractory angina pectoris.

Future Cardiol 2022 Jul 27;18(7):523-537. Epub 2022 Jun 27.

Interventional Cardiology Unit, GVM Care & Research Maria Cecilia Hospital, Via Madonna di Genova 1, Cotignola, RA, 48033, Italy.

Refractory angina represents the final stage of chronic coronary artery disease, where anginal symptoms persist despite complete epicardial coronary artery revascularization and maximally tolerated pharmacological therapy. Percutaneous narrowing of the coronary sinus with the coronary sinus reducer (Reducer, Neovasc, Inc., Richmond, Canada) device was first attempted in humans in 2005 and has been shown to improve angina symptoms and the quality of life of patients suffering chronic refractory angina. Read More

View Article and Full-Text PDF

Tip detection-antegrade dissection and reentry using intravascular ultrasound in chronic total occlusion intervention: first human case report.

Eur Heart J Case Rep 2022 Jun 10;6(6):ytac233. Epub 2022 Jun 10.

Cardiovascular Center, Sakurabashi Watanabe Hospital, 2-4-32 Umeda, Kita-ku, Osaka 530-0001, Japan.

Background: It has been considered impossible to perform antegrade dissection and reentry (ADR) by simply puncturing with a guidewire using the intravascular ultrasound (IVUS) observation without the support of the Stingray system.

Case Summary: A 78-year-old man suffered from effort angina pectoris due to a chronic total occlusion (CTO) lesion in the left circumflex coronary artery. A retry percutaneous coronary intervention for the CTO lesion was attempted at our hospital. Read More

View Article and Full-Text PDF

Long-Term Outcomes for Chinese COPD Patients After PCI: A Propensity Score Matched, Double-Cohort Study.

Front Cardiovasc Med 2022 9;9:827635. Epub 2022 Jun 9.

Department of Cardiology and Institute of Vascular Medicine, Peking University Third Hospital, NHC Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides, Key Laboratory of Molecular Cardiovascular Science, Ministry of Education, Beijing Key Laboratory of Cardiovascular Receptors Research, Beijing, China.

Objectives: The aim of this study was to analyze long-term outcomes of Chinese coronary artery disease (CAD) patients with (and without) chronic obstructive pulmonary disease (COPD) after percutaneous coronary intervention (PCI).

Background: Chronic obstructive pulmonary disease is a chronic condition which often develops in conjunction with CAD. PCI is a core therapy for CAD, although we still need to understand CAD-COPD outcomes and to identify factors that influence prognoses, across ethnicities. Read More

View Article and Full-Text PDF

Addressing unmeasured confounding bias with a prior knowledge guided approach: coronary artery bypass grafting (CABG) versus percutaneous coronary intervention (PCI) in patients with stable ischemic heart disease.

Health Serv Outcomes Res Methodol 2022 Jun 21:1-21. Epub 2022 Jun 21.

Kaiser Permanente Center for Effectiveness and Safety Research and the Bernard J. Tyson School of Medicine, Pasadena, CA USA.

Unmeasured confounding undermines the validity of observational studies. Although randomized clinical trials (RCTs) are considered the "gold standard" of study types, we often observe divergent findings between RCTs and empirical settings. We present the "L-table", a simulation-based, prior knowledge (e. Read More

View Article and Full-Text PDF

Non-pulmonary complications after lung transplantation: Part I.

Indian J Thorac Cardiovasc Surg 2022 Jul 8;38(Suppl 2):280-289. Epub 2021 Oct 8.

Lung Transplant Program, University of Texas Southwestern Medical Center, 5939 Harry Hines Blvd. Suite 603, Dallas, TX 75235-8550 USA.

Lung transplantation (LT) is a viable therapeutic option in the treatment of advanced lung disease. With improvements in post-transplant survival, complications involving different organ systems after LT are increasingly seen. While non-infectious, extrapulmonary complications after LT are not frequently responsible for early post-transplant mortality, they significantly impact the quality of life and long-term survival. Read More

View Article and Full-Text PDF

Pseudo Subarachnoid Hemorrhage Sign in Bacterial Meningitis in a Patient Presenting With Acute Ischemic Stroke: A Novel Radiological Clue to Rapid Diagnosis.

Cureus 2022 May 24;14(5):e25283. Epub 2022 May 24.

Neuroradiology, Prisma Health Greenville Memorial Hospital, Greenville, USA.

Pseudo subarachnoid hemorrhage (SAH) is an entity defined when characteristic computed tomography (CT) findings of SAH are seen without evidence of hemorrhage on MRI, autopsy, or cerebrospinal fluid analysis. This imaging phenomenon has been reported in association with multiple clinical settings including diffuse cerebral edema, hypoxic-ischemic injury, post percutaneous coronary intervention, and the focus of our report, acute bacterial meningitis. The mechanisms leading to this finding are poorly understood. Read More

View Article and Full-Text PDF

A Stratified Analysis of the Risk Associated With Low Body Mass Index for Patients After Percutaneous Coronary Intervention.

J Atheroscler Thromb 2022 Jun 25. Epub 2022 Jun 25.

Department of Cardiology, University of Yamanashi, Faculty of Medicine.

Aims: The relationship between low body mass index (BMI) and prognostic factors for patients with coronary artery disease, commonly observed in elderly individuals in Japan, is important. Few studies have evaluated the prognosis for patients with low BMI after percutaneous coronary intervention (PCI). Using a multivariable-adjusted model and data from a prospective cohort registry, we analyzed the risk associated with low BMI for patients after PCI. Read More

View Article and Full-Text PDF

Radial versus femoral access in ACS patients undergoing complex PCI is associated with consistent bleeding benefit and no excess of risks.

Can J Cardiol 2022 Jun 23. Epub 2022 Jun 23.

Division of Cardiology, Cardiocentro Ticino Institute, Ente Ospedaliero Cantonale (EOC), Lugano, Switzerland; Department of Biomedical Sciences, University of Italian Switzerland, Lugano, Switzerland. Electronic address:

Background: The comparative effectiveness of transradial (TRA) compared with transfemoral access (TFA) in acute coronary syndrome (ACS) patients undergoing complex percutaneous coronary intervention (PCI) remains unclear.

Methods: Among 8,404 ACS patients in the Minimizing Adverse Haemorrhagic Events by TRansradial Access Site and Systemic Implementation of angioX (MATRIX)-Access trial, 5,233 underwent noncomplex (TRA, n=2,590 and TFA, n=2,643) and 1,491 complex PCI (TRA, n=777 and TFA, n=714). Co-primary outcomes were major adverse cardiovascular events (MACE, the composite of all-cause mortality, myocardial infarction, or stroke) and the composite of MACE and BARC type 3-5 bleeding (net adverse cardiovascular events, NACE) at 30 days. Read More

View Article and Full-Text PDF